共 50 条
- [2] Disrupting B and T-cell collaboration in autoimmune disease: T-cell engagers versus CAR T-cell therapy? [J]. CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2024, 217 (01): : 15 - 30
- [3] T-Cell Cancer after CAR T-Cell Therapy [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2024, 390 (22): : 2120 - 2121
- [4] Safer CAR T-Cell Therapy [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2019, 321 (22): : 2155 - 2155
- [6] CAR T-Cell Therapy for Glioblastoma [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2024, 390 (14): : 1329 - 1332
- [9] Caring for Patients on CAR T-Cell Therapy in the Inpatient Versus Outpatient Setting [J]. ONCOLOGY-NEW YORK, 2022, 36 (07): : 466 - 470
- [10] The Fate(s) of CAR T-Cell Therapy: Navigating the Risks of CAR+ T-Cell Malignancy [J]. BLOOD CANCER DISCOVERY, 2024, 5 (04): : 249 - 257